IDEAS home Printed from https://ideas.repec.org/a/sae/sajbmc/v8y2019i1p100-110.html
   My bibliography  Save this article

Biocon: Taking a Crack at the Global Biosimilar Market

Author

Listed:
  • Soma Dey

Abstract

India’s first biotechnology company, Biocon, has developed into a fully integrated biotechnology company with an impressive portfolio of small molecule generic drugs as well as new research initiatives. From 2007, Biocon has started paying attention to the new market for biologics and biosimilars. The current global biosimilar market is worth US$3.3 billion with an expected growth rate of 25 per cent. Over a decade of research, strategic collaborations and acquisition of strategic assets have enabled Biocon to become the leading biosimilar manufacturer in India. However, the biosimilar market remains a difficult market globally. The complex manufacturing process of biosimilars makes it harder to manufacture quality biosimilars. The regulatory environments in different countries are a major challenge. Also, various other large global pharmaceutical companies are actively seeking access to this market, thereby increasing competition for all. Biocon has to face all these issues as it goes ahead with an outward-looking plan of expanding its biosimilar and biologics portfolio.

Suggested Citation

  • Soma Dey, 2019. "Biocon: Taking a Crack at the Global Biosimilar Market," South Asian Journal of Business and Management Cases, , vol. 8(1), pages 100-110, April.
    • Handle: RePEc:sae:sajbmc:v:8:y:2019:i:1:p:100-110
    DOI: 10.1177/2277977918803186
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/2277977918803186
    Download Restriction: no
    File URL: https://libkey.io/10.1177/2277977918803186?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Pradhan, Jaya Prakash, 2003. "Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry," MPRA Paper 17079, University Library of Munich, Germany.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mithun Nandy, 2020. "Is There Any Impact of R&D on Financial Performance? Evidence from Indian Pharmaceutical Companies," FIIB Business Review, , vol. 9(4), pages 319-334, December.
    2. Shilpi Tyagi & D. K. Nauriyal & Rachita Gulati, 2018. "Firm level R&D intensity: evidence from Indian drugs and pharmaceutical industry," Review of Managerial Science, Springer, vol. 12(1), pages 167-202, January.
    3. Rituparna Kaushik & Sourabh Bikas Paul, 2022. "Do Competition Improve Persistence in Innovation Effort? Sectoral Patterns and Evidence from India," Journal of Industry, Competition and Trade, Springer, vol. 22(2), pages 259-296, June.
    4. Loitongbam, Bishwanjit Singh, 2016. "Globalization and Innovation in the Indian Pharmaceutical Industry," MPRA Paper 75925, University Library of Munich, Germany, revised 27 May 2016.
    5. Pradhan, Jaya Prakash, 2004. "FDI spillovers and local productivity growth: evidence from Indian pharmaceutical industry," MPRA Paper 17080, University Library of Munich, Germany.
    6. H Saranga & R D Banker, 2010. "Productivity and technical changes in the Indian pharmaceutical industry," Journal of the Operational Research Society, Palgrave Macmillan;The OR Society, vol. 61(12), pages 1777-1788, December.
    7. Oleg S. Mariev & Karina M. Nagieva & Viktoria L. Simonova, 2020. "Managing innovation activity factors in Russian regions through econometric modeling," Upravlenets, Ural State University of Economics, vol. 11(1), pages 57-69, March.
    8. Bhargavi Jayanthi & S.N.V. Sivakumar & Arunima Haldar, 2016. "Cross-border Acquisitions and Host Country Determinants: Evidence from Indian Pharmaceutical Companies," Global Business Review, International Management Institute, vol. 17(3), pages 684-699, June.
    9. Pradhan, Jaya Prakash, 2010. "R&D strategy of small and medium enterprises in India: Trends and determinants," MPRA Paper 20951, University Library of Munich, Germany.
    10. Jaya Prakash Pradhan, "undated". "Global competitiveness of Indian Pharmaceutical Industry: Trends and Strategies," Working Papers 0605, Institute for Studies in Industrial Development (ISID).
    11. Pradhan, Jaya Prakash, 2011. "Regional heterogeneity and firms’ innovation: the role of regional factors in industrial R&D in India," MPRA Paper 28096, University Library of Munich, Germany.
    12. K.J. Joseph, 2005. "Strategic Approach to Strengthening the International Competitiveness in Knowledge Based Industries : Electronics Industry," Microeconomics Working Papers 22102, East Asian Bureau of Economic Research.
    13. Teirlinck, Peter & Khoshnevis, Pegah, 2020. "Within-cluster determinants of output efficiency of R&D in the space industry," Omega, Elsevier, vol. 94(C).
    14. Keshari, Pradeep Kumar, 2013. "Comparative performance of foreign affiliates and domestic firms in the Indian machinery industry," MPRA Paper 33076, University Library of Munich, Germany, revised 20 Apr 2013.
    15. Raveendra Chittoor & MB Sarkar & Sougata Ray & Preet S. Aulakh, 2009. "Third-World Copycats to Emerging Multinationals: Institutional Changes and Organizational Transformation in the Indian Pharmaceutical Industry," Organization Science, INFORMS, vol. 20(1), pages 187-205, February.
    16. Swati Mehta, 2014. "Strategies of Technology Accumulation by Indian Pharmaceutical Firms: A Multinomial Logit Analysis," Millennial Asia, , vol. 5(1), pages 67-87, April.
    17. Chittoor, Raveendra & Ray, Sougata & Aulakh, Preet S. & Sarkar, M.B., 2008. "Strategic responses to institutional changes: 'Indigenous growth' model of the Indian pharmaceutical industry," Journal of International Management, Elsevier, vol. 14(3), pages 252-269, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:sajbmc:v:8:y:2019:i:1:p:100-110. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.